10-Q: Healthcare Realty Trust Reports Q2 Loss Amid Property Impairments and Strategic Dispositions
Quarterly Report
Healthcare Realty Trust reported a net loss of $160.1 million for the second quarter of 2025, primarily due to significant real estate impairments and decreased rental income from property dispositions, while also securing a key credit facility extension.
Summary
- Net loss for the three months ended June 30, 2025, was $160.1 million, compared to a net loss of $145.9 million for the same period in 2024.
- Net loss for the six months ended June 30, 2025, was $205.5 million, a significant improvement from the $461.2 million loss in the prior year period, which included a $250.5 million goodwill impairment.
- Rental income decreased by $21.1 million (6.8%) to $287.1 million for the three months ended June 30, 2025, primarily due to dispositions in 2024 and 2025.
- Real estate impairments totaled $140.9 million for the three months and $151.0 million for the six months ended June 30, 2025, impacting 13 properties due to changes in expected holding periods and 2 properties sold.
- A credit loss reserve of $1.5 million was recorded on a mortgage note receivable in the second quarter of 2025.
- Funds From Operations (FFO) attributable to common stockholders was $120.4 million ($0.34 per diluted share) for the three months ended June 30, 2025, compared to $123.8 million ($0.33 per diluted share) for the same period in 2024.
- Normalized FFO attributable to common stockholders was $143.7 million ($0.41 per diluted share) for the three months ended June 30, 2025, compared to $143.5 million ($0.38 per diluted share) for the same period in 2024.
- Funds Available for Distribution (FAD) was $115.4 million for the three months ended June 30, 2025, up from $107.6 million in the prior year period.
- Cash and cash equivalents decreased to $25.5 million as of June 30, 2025, from $68.9 million at December 31, 2024.
- Total real estate properties, net, decreased to $8.67 billion as of June 30, 2025, from $9.33 billion at December 31, 2024.
- Assets held for sale, net, significantly increased to $358.2 million as of June 30, 2025, from $12.9 million at December 31, 2024, reflecting 25 properties and a land parcel designated for sale.
- Disposed of eight medical outpatient properties and two land parcels for a total sales price of $81.2 million during the six months ended June 30, 2025.
- Subsequent to June 30, 2025, four additional properties were disposed of for $129.35 million.
- Entered into a Fifth Amended and Restated Revolving Credit and Term Loan Agreement on July 25, 2025, extending the $1.5 billion Revolver maturity to July 25, 2029.
- Incurred $158.4 million in capital costs during the six months ended June 30, 2025, primarily for development, redevelopment, and tenant improvements.
- Declared a quarterly common stock dividend of $0.24 per share payable on August 28, 2025.
- The company had $237.0 million remaining under its stock repurchase authorization as of June 30, 2025, with no shares repurchased in 2025.
Sentiment
Score: 4
Explanation: The company's financial results show a significant net loss and substantial real estate impairments, indicating a challenging operating environment and asset value adjustments. While the extension of the credit facility provides crucial liquidity and debt management flexibility, and Normalized FFO/FAD per share show some resilience, the overall decline in cash and rental income, coupled with the need to use debt for dividends, points to underlying pressures. The ongoing tenant bankruptcy also adds uncertainty.
Positives
- Normalized FFO per diluted share increased to $0.41 in Q2 2025 from $0.38 in Q2 2024, indicating improved operational performance when excluding certain non-cash items.
- Funds Available for Distribution (FAD) increased to $115.4 million in Q2 2025 from $107.6 million in Q2 2024, suggesting stronger cash flow available for distribution.
- Successfully entered into a Fifth Amended and Restated Revolving Credit and Term Loan Agreement on July 25, 2025, extending the $1.5 billion Revolver maturity to July 25, 2029, enhancing liquidity and capital structure flexibility.
- Repaid $250 million Senior Notes due 2025 at maturity in May 2025, demonstrating effective debt management.
- Leasing activity contributed to a $13.4 million increase in rental income for the three months ended June 30, 2025.
- The tenant retention ratio for the first six months of 2025 was within the expected range of 75% to 90%, indicating stable tenant relationships.
- Management believes current liquidity and capital sources are adequate to satisfy cash requirements, including funding dividends for the full year 2025.
Negatives
- Net loss increased to $160.1 million in Q2 2025 from $145.9 million in Q2 2024, reflecting a deterioration in GAAP profitability.
- Recognized significant real estate impairments totaling $140.9 million in Q2 2025 and $151.0 million for the six months ended June 30, 2025, indicating a decline in asset values.
- Rental income decreased by $21.1 million (6.8%) in Q2 2025 and $50.3 million (8.0%) for the six months ended June 30, 2025, primarily due to the impact of property dispositions.
- General and administrative expenses increased by $9.5 million (67.7%) in Q2 2025, largely driven by $10.3 million in restructuring and severance-related charges.
- Cash and cash equivalents significantly decreased from $68.9 million at December 31, 2024, to $25.5 million at June 30, 2025.
- Cash flows from operations were not adequate to fully fund dividends for the six months ended June 30, 2025, requiring the use of the Unsecured Credit Facility.
- Recorded a $1.5 million credit loss reserve on a mortgage note receivable in Q2 2025, highlighting potential credit quality issues.
- Exposure to the Prospect Medical bankruptcy, with approximately $2.9 million in annual revenue at risk and uncertainty regarding the recovery of unpaid rent.
Risks
- Expected results may not be achieved.
- Revenues depend on the ability of tenants to generate sufficient income to make rental payments, with specific negative impacts from Steward Health and Prospect Medical bankruptcies.
- Owning real estate and indirect interests in real estate is subject to inherent risks.
- The company may incur additional impairment charges on its real estate properties or other assets.
- Properties subject to purchase options expose the company to reinvestment risk and reduction in expected investment returns.
- Inability to promptly re-let properties, lower re-letting rates, or significant expenditures/concessions to attract new tenants could adversely affect business, financial condition, and results of operations.
- Certain properties are special purpose healthcare facilities and may not be easily adaptable to other uses.
- Exposure to fixed rent escalators which could lag behind inflation and growth in operating expenses (e.g., real estate taxes, utilities, insurance, maintenance).
- Real estate investments are illiquid, potentially limiting strategic dispositions.
- Risks associated with the development and redevelopment of properties, including significant fund expenditure and potential underperformance.
- Exposure to risks associated with geographic concentration.
- Revenue concentrations relating to leases dependent on the viability of associated health systems.
- Many properties are held under ground leases, which may limit the company's ability to lease, sell, or finance these properties.
- The company may experience uninsured or underinsured losses.
- Damage from catastrophic weather and other natural events could result in losses.
- Risks associated with security breaches through cyber attacks or other significant disruptions of information technology networks.
- Acquisitions structured in exchange for limited partnership units of the OP could limit liquidity or flexibility.
- Healthcare Realty Trust is a holding company relying on funds from the OP, structurally subordinating stockholders' interests to OP liabilities.
- Uncertainty regarding the ability to continue paying dividends at or above previously paid rates.
- Pandemics and measures to prevent their spread could have a material adverse effect on business.
- Success depends on attracting and retaining talented employees; loss of key personnel could adversely impact business.
- Significant debt obligations and potential for increased leverage in the future.
- Covenants in debt instruments limit operational flexibility, and a breach could materially affect financial condition.
- If lenders under the Unsecured Credit Facility fail to meet funding commitments, operations and financial position would be negatively impacted.
- Unavailability of equity and debt capital, volatility in credit markets, increases in interest rates, or changes in debt ratings could adversely affect ability to meet debt payments, make dividend payments, or engage in acquisition/development.
- Increases in interest rates could have a material adverse effect on the cost of capital.
- Swap agreements may not effectively reduce exposure to changes in interest rates.
- Joint venture agreements limit flexibility with respect to jointly owned properties.
- Unclear U.S. federal income tax treatment of cash from forward equity agreements could jeopardize REIT qualification.
- Automatic termination of forward equity agreements in case of bankruptcy or insolvency, resulting in loss of expected proceeds.
- Property taxes could increase due to reassessment or property tax rate changes.
- Trends in the healthcare service industry, including the 'One Big Beautiful Bill Act,' may negatively affect demand for properties, lease revenues, and investment values.
- Costs of complying with governmental laws and regulations may adversely affect results of operations.
- Qualifying as a REIT involves highly technical and complex provisions of the Internal Revenue Code; failure to qualify would lead to significant adverse consequences.
- Articles of incorporation and Maryland General Corporation Law (MGCL) provisions contain limits and restrictions on transferability of common stock, which may have adverse effects on its value.
- Complying with REIT requirements may cause the company to forego otherwise attractive opportunities.
- The prohibited transactions tax may limit the company's ability to sell properties.
- New legislation or administrative or judicial action could make it more difficult or impossible to qualify as a REIT.
- New and increased transfer tax rates may reduce the value of properties.
Future Outlook
Management expects cash flows from operations to generate sufficient cash flows during 2025 to fund dividends for the full year, potentially supplemented by other liquidity sources. The company anticipates approximately 15% of its leases to expire annually, with an expected tenant retention rate of 75% to 90%. Compliance with the new ASU 2024-03 regarding disaggregation of income statement expenses will begin with the Annual Report on Form 10-K for the year ended December 31, 2027.
Management Comments
- "Management believes that the Company's liquidity and sources of capital are adequate to satisfy its cash requirements."
- "The Company expects that cash flows from operations will generate sufficient cash flows during 2025 such that dividends for the full year 2025 can be funded by cash flows from operations or other sources of liquidity described above."
- "The Company typically expects to retain 75% to 90% of tenants upon expiration, and the retention ratio for the first six months of the year was within this range."
Industry Context
The company operates within the U.S. healthcare real estate sector, specializing in outpatient services properties. The filing highlights broader industry challenges such as rising interest rates and increased capital market volatility, which impact the cost and availability of debt and equity capital for REITs. These conditions can also lead to less liquid property markets, affecting asset sales and joint venture capital. The company's financial performance is also influenced by the viability of healthcare systems, as evidenced by its exposure to tenant bankruptcies like Prospect Medical, a risk inherent in the healthcare provider segment of the REIT industry. Regulatory changes, such as the mentioned 'One Big Beautiful Bill Act,' also pose potential impacts on demand and lease revenues.
Comparison to Industry Standards
- The company utilizes Funds From Operations (FFO) and Funds Available for Distribution (FAD) as key performance indicators, aligning with measures adopted by the National Association of Real Estate Investment Trusts (NAREIT) for evaluating REIT operating performance.
- The company's tenant retention ratio for the first six months of 2025 was within its typical expected range of 75% to 90%, indicating performance consistent with its internal benchmarks.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Vice President and Chief Administrative Officer | Julie F. Wilson | December 31, 2025 | Departure pursuant to termination without cause provisions of employment agreement. | |
| Senior Vice President, Legal Affairs (previously Executive Vice President and General Counsel) | John M. Bryant, Jr. | December 31, 2025 | Departure pursuant to termination without cause provisions of employment agreement. |
Legal Proceedings
- The company is involved in litigation arising in the ordinary course of business, but is not aware of any pending or threatened litigation that would have a material adverse effect on its consolidated financial position, results of operations, or cash flows.
- Prospect Medical Holdings filed for Chapter 11 bankruptcy on January 11, 2025, impacting leases accounting for approximately $2.9 million of annual revenue, with ongoing discussions regarding these leases.
Stakeholder Impact
- Shareholders: Experienced an increased net loss and significant real estate impairments, but also saw a slight increase in Normalized FFO and FAD per share. Dividends were declared, but cash flow from operations was insufficient to fully fund them for the first six months, requiring reliance on the credit facility. A stock repurchase program is authorized, but no repurchases occurred in 2025.
- Employees: The company incurred restructuring and severance-related charges of $10.3 million in Q2 2025 and $10.8 million for the first half of 2025. Two senior executives are departing at the end of 2025. Share-based compensation awards were granted.
- Tenants: Some tenants, like Prospect Medical, are facing financial distress (bankruptcy), which impacts the company's rental income. Tenants are also subject to broader economic conditions and rising interest rates.
- Creditors: The company has significant debt obligations, but successfully extended the maturity of its $1.5 billion revolving credit facility to July 2029, providing stability. Interest rate swaps are in place to manage interest rate risk on variable-rate debt.
Next Steps
- Continue efforts to appeal property tax increases and manage their impact across the portfolio.
- Monitor industry and economic conditions, credit enhancements, liquidity, and other factors to evaluate the collectability of loan receivables on a quarterly basis.
- Evaluate the impact of the adoption of Accounting Standards Update (ASU) 2024-03 on consolidated financial statements, with compliance beginning in the Annual Report on Form 10-K for the year ended December 31, 2027.
- Generate sufficient cash flows from operations during 2025 to fund dividends for the full year, or utilize other sources of liquidity.
- Manage the transition of two senior executives, Julie F. Wilson and John M. Bryant, Jr., who will depart their positions effective December 31, 2025.
Key Dates
| Date | Description |
|---|---|
| December 31, 2024 | End of previous fiscal year for comparative balance sheet data. |
| January 11, 2025 | Prospect Medical Holdings filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code. |
| January 2025 | Received $14.9 million payment towards the principal balance of a mortgage loan; repaid $25.0 million of the $200 million Unsecured Term Loan; repaid $10.0 million of the $300 million Unsecured Term Loan. |
| February 7, 2025 | Disposed of a property in Boston, MA. |
| February 11, 2025 | Granted an aggregate of 275,735 Restricted Stock Units (RSUs) and 166,976 LTIP Series C Units to senior management. |
| February 14, 2025 | Disposed of two medical outpatient properties in Denver, CO. |
| March 20, 2025 | Disposed of a property in Houston, TX; executed a mezzanine loan receivable agreement with a maximum loan commitment of $8.5 million. |
| April 8, 2025 | Exercised the second of two options to extend the maturity date of the $200 million Unsecured Term Loan due May 2025 to January 2026. |
| April 15, 2025 | Granted 347,770 LTIP Series C Units to the newly appointed Chief Executive Officer. |
| April 2025 | A mortgage loan receivable of $37.7 million maturing in February 2026 was repaid in full. |
| April 30, 2025 | Disposed of a property in Boston, MA. |
| May 1, 2025 | Repaid Senior Notes due 2025 at maturity, including $250 million of principal and $4.8 million of accrued interest. |
| May 23, 2025 | Disposed of a property in Boston, MA. |
| June 26, 2025 | Disposed of properties in Jacksonville, FL and Yakima, WA. |
| June 27, 2025 | Disposed of a property in Houston, TX. |
| June 30, 2025 | End of the quarterly period covered by this Form 10-Q. |
| July 15, 2025 | Disposed of a property in South Bend, IN (subsequent to period end). |
| July 25, 2025 | Entered into the Fifth Amended and Restated Revolving Credit and Term Loan Agreement (New Credit Facility), extending the $1.5 billion Revolver maturity to July 25, 2029. |
| July 29, 2025 | Disposed of properties in Milwaukee, WI and Naples, FL (subsequent to period end). |
| July 30, 2025 | Disposed of a property in New York, NY (subsequent to period end). |
| July 31, 2025 | Declared a quarterly common stock dividend of $0.24 per share; Julie F. Wilson and John M. Bryant, Jr. determined to depart their positions effective December 31, 2025. |
| August 1, 2025 | Date of filing of the Form 10-Q. |
| August 14, 2025 | Record date for the quarterly common stock dividend declared on July 31, 2025. |
| August 28, 2025 | Payment date for the quarterly common stock dividend declared on July 31, 2025. |
| December 31, 2025 | Effective date of departure for Julie F. Wilson and John M. Bryant, Jr. |
| December 15, 2026 | Effective date for annual reporting periods for new Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses. |
| December 15, 2027 | Effective date for interim reporting periods for new ASU 2024-03. |
Recommendation
holdThe company's financial performance presents a mixed picture, warranting a 'Hold' recommendation for a seasoned investor. While the significant net loss and substantial real estate impairments are concerning, indicating asset value pressures and a challenging operating environment, the company has taken proactive steps to manage its capital structure by extending its $1.5 billion revolving credit facility. This extension provides crucial liquidity and flexibility, mitigating immediate debt maturity risks. Furthermore, the slight increase in Normalized FFO and FAD per share, when adjusting for non-cash items, suggests some underlying operational resilience. The company is actively managing its portfolio through dispositions and redevelopments. However, the decline in cash and cash equivalents and the reliance on the credit facility to fund dividends for the first half of the year highlight ongoing liquidity management challenges. Given these offsetting factors, a 'Hold' position allows investors to monitor the company's ability to stabilize its portfolio, improve cash flow generation to consistently cover dividends, and navigate the prevailing real estate and interest rate landscape.
Keywords
Healthcare Realty Trust, REIT, Medical Office Buildings, Outpatient Facilities, Real Estate, SEC Filing, 10-Q, Financial Results, Property Dispositions, Impairment Charges, Debt Restructuring, Credit Facility, Dividends, Capital Expenditures, Financial Performance, Corporate Governance, Risk Management, Healthcare Real Estate
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.